[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353046-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353046-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","stabilised-hyaluronic-acid-gel-rectal-spacers-in-mri-guided-brachytherapy-for-gynaecological-cancers-a-prospective-feasibility-study","Stabilised Hyaluronic Acid Gel Rectal Spacers in MRI-Guided Brachytherapy for Gynaecological Cancers - A Prospective Feasibility Study","","Evaluate insertion feasibility of a stabilised hyaluronic acid (sHA) gel rectal spacer in MRI-guided high dose rate brachytherapy for gynaecological cancers. A single-institution prospective study enrolled patients receiving GynBT, assessing technical success, clinician usability, MRI spacer visibility, and stability across the treatment course. Twelve patients underwent insertion without spacer-related complications; clinicians reported ease of use and high visibility on TRUS and MRI. Target-to-rectum distance increased, while spacer volume and craniocaudal distance decreased; overall target-to-rectum and spacer level measures remained unchanged. Further studies are needed to confirm suitability, dosimetry, patient outcomes, toxicities, and optimal technique.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/stabilised-hyaluronic-acid-gel-rectal-spacers-in-mri-guided-brachytherapy-for-gynaecological-cancers-a-prospective-feasibility-study/353046/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/stabilised-hyaluronic-acid-gel-rectal-spacers-in-mri-guided-brachytherapy-for-gynaecological-cancers-a-prospective-feasibility-study/353046.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the prospective study?","Question",{"text":63,"@type":64},"To evaluate the insertion feasibility of a stabilised hyaluronic acid (sHA) gel rectal spacer in MRI-guided high dose rate brachytherapy for gynaecological cancers, including safety, visibility, and stability across the treatment course.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was feasibility assessed in this study?",{"text":68,"@type":64},"Feasibility was assessed by technical success, clinician user experience, spacer visibility on MRI, and spacer stability over the GynBT course.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings regarding spacer performance during treatment?",{"text":72,"@type":64},"Insertion was achieved in all 12 patients without spacer-related complications, with high visibility on TRUS and excellent visibility on MRI. Target-to-rectum distance increased, while spacer volume and craniocaudal distance decreased during GynBT without significant changes in target-to-rectum distance or spacer level measurements.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353046,1790552595,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Journal of Medical Radiation Sciences  \nORIGINAL ARTICLE  OPEN ACCESS   \nStabilised Hyaluronic Acid Gel Rectal Spacers in  \nMRI-Guided Brachytherapy for Gynaecological Cancers: A Prospective Feasibility Study  \nCarminia Lapuz1,2  | Sylvia Hanna1 | Eddie Lau3,4  | Adeline Lim1 | Mark Tacey1 | Daryl Lim Joon1,2  | Claire Dempsey5,6,7 | Jenny Sim2  | Michael Chao1,2   \n1Department of Radiation Oncology, Austin Health, Melbourne, Victoria, Australia | 2Department of Medical Imaging and Radiation Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia | 3Department of Radiology, Austin Health, Melbourne, Victoria, Australia | 4Department of Radiology, University of Melbourne, Melbourne, Victoria, Australia | 5Department of Radiation Oncology, Calvary Mater Newcastle, Newcastle, New South Wales, Australia | 6School of Health Sciences, University of Newcastle, Newcastle, New South Wales,  \nAustralia | 7Department of Radiation Oncology, University of Washington, Seattle, Washington, USA Correspondence: Carminia Lapuz ([carminia.lapuz@austin.org.au](carminia.lapuz@austin.org.au))  \nReceived: 19 September 2025 | Revised: 13 November 2025 | Accepted: 24 November 2025  \nKeywords: brachytherapy | cervical cancer | gynaecological | hyaluronic acid | rectal spacer  \nABSTRACT  \nIntroduction: To evaluate insertion feasibility of a stabilised hyaluronic acid (sHA) gel rectal spacer in gynaecological cancer high dose rate brachytherapy (GynBT) .  \nMethods: This single institution prospective study included patients with gynaecological cancers receiving magnetic resonance imaging (MRI)-guided GynBT. Feasibility was assessed by technical success, clinician user experience, spacer visibility on MRI and spacer stability over the GynBT course.  \nResults: Twelve patients were included in this study. Insertion of sHA gel into the rectovaginal space was achieved in all 12 patients without spacer-related complications. Clinicians reported sHA gel as easy to use, with high visibility on TRUS (rated 4–5) and excellent visibility on MRI. Target-to-rectum distance increased with sHA spacer insertion (mean 7.82 mm, 95% CI: 5.27–10.36, p\u003C 0.001). During GynBT, there was a reduction in sHA gel spacer volume (mean 1.75 cc, 95% CI: 0.57–2.93, p = 0.007) and craniocaudal distance (mean −3.87 mm, 95% CI: −7.37 to −0.36, p = 0.034) . However, there were no significant changes in target-to-rectum distance (p = 0.490) and spacer level measurements (p >0.2) .  \nConclusion: Insertion of sHA gel rectal spacer is technically feasible and safe in GynBT, increasing the separation between the target and rectum. The sHA gel spacer is easy to use, highly visible on both TRUS and MRI, and stable during the entire GynBT course. Further studies are required to ascertain patient suitability, dosimetric comparison, patient-reported outcomes, toxicities, and optimal technique.  \nTrial Registration: The study was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12625000167460)  \n1 | Introduction  \nMagnetic resonance imaging (MRI)-guided brachytherapy isan important treatment modality in the management of gynaecological cancers, enabling precise targeting of the tumour  \nwhile sparing nearby organs at risk (OARs) [1] . Rectal morbidity remains a concern, with studies reporting grade 2 and above rectal toxicity rates up to 29%[2–4] . The EMBRACE study established dose-volume relationships between rectal dose and late rectal morbidity, suggesting a rectal D2cc less  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Journal of Medical Radiation Sciences published by John Wiley & Sons Australia, Ltd on behalf of Australian Society of Medical Imaging and Radiation Therapy and New Zealand Institute of Medical Radiation Technology.  \n196 Jo","cbCaiejhwuEG5Hv0","https://ap.wps.com/l/cbCaiejhwuEG5Hv0","pdf",630901,"English","# Abstract\n## Introduction\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What was the main objective of the prospective study?\",\"answer\":\"To evaluate the insertion feasibility of a stabilised hyaluronic acid (sHA) gel rectal spacer in MRI-guided high dose rate brachytherapy for gynaecological cancers, including safety, visibility, and stability across the treatment course.\"},{\"question\":\"How was feasibility assessed in this study?\",\"answer\":\"Feasibility was assessed by technical success, clinician user experience, spacer visibility on MRI, and spacer stability over the GynBT course.\"},{\"question\":\"What were the key findings regarding spacer performance during treatment?\",\"answer\":\"Insertion was achieved in all 12 patients without spacer-related complications, with high visibility on TRUS and excellent visibility on MRI. Target-to-rectum distance increased, while spacer volume and craniocaudal distance decreased during GynBT without significant changes in target-to-rectum distance or spacer level measurements.\"}]","Stabilised Hyaluronic Acid Gel Rectal Spacers in MRI-Guided Brachytherapy for Gynaecological Cancers - A Prospective Feasibility Study | PDF",1790102717,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/538d0d4a859566312ba9a449ffd18065.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9d0b0364cf4dc19fe8a50462a978c8a.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38bf00ccdd56fb16ef148fc1e3bfb84a.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b6d709a9fed2b4e146ca172f7d9a56f.webp",980,1287]